Aggarwal BB. 2010. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr, 30: 173-199.
Aggarwal BB, Kumar A, Aggarwal MS, Shishodia S. 2005. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. Phytopharmaceutic Cancer Chemoprev, 23: 351-387.
Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. 2008. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer lett, 267: 133-164.
Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Borén J, Catapano AL, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P. 2011. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J, 32(11):1345-1361.
Curb JD, Abbott RD, Rodriguez BL, Masaki K, Chen R, Sharp DS, Tall AR. 2004. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res, 45: 948-953.
Davidson MH. 2012. HDL and CETP inhibition: will this DEFINE the future?.Curr Treat Options Cardiovasc Med, 14: 384-390.
Elseweidy MM, Younis NN, Elswefy SE, Abdallah FR, El-Dahmy SI, Elnagar G, Kassem HM. 2015. Atheroprotective potentials of curcuminoids against ginger extract in hypercholesterolaemic rabbits. Nat Prod Res, 29: 961-965.
Epstein J, Sanderson IR, MacDonald TT. 2010. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J nutr 103:1545-1557.
Fisher EA, Feig JE, Hewing B, Hazen SL, Smith JD. 2012. High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler Thromb Vasc Biol, 32: 2813-2820.
Ghatreh-Samani K, Farrokhi E, Hashemzadeh-Chaleshtori M, Nikookar M, Noormohammadian Z. 2012. Study of I405V polymorphism of cholesterol ester transfer protein gene in efficacy of statins on plasma level of high density lipoprotein cholesterol. J Shahrekord Univ Med Sci, 14: 1-10.
Julie S, Jurenka M. 2009. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa. A preclinical and clinical research. Altern Med Rev, 14: 277.
Kidd PM. 2009. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev, 14: 226-46.
Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. 2006. Multiple biological activities of curcumin: a short review. Life Sci,78: 2081-2087.
Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ. 2007. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol, 601: 71-7.
Rahimi HR, Mohammadpour AH, Dastani M, Jaafari MR, Abnous K, Mobarhan MG and Oskuee RK. 2016. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna J Phytomed, 6: 567.
Ritchie S, Connell JM. 2007. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis, 17: 319-326.
Saberi-Karimian M, Parizadeh SMR, Ghayour-Mobarhan M, Moammeri SM, Fathi DB, Safarian H, Javandoost A, Ferns GA, Sahebkar A, Ahmadinejad M. 2018. Evaluation of the effects of curcumin in patients with metabolic syndrome. Comp Clin Pathol, 2018: 1-9.
Sahebkar A. 2014. Curcuminoids for the management of hypertriglyceridaemi. Nat Rev Cardiol, 11: 123-123.
Sandhofer A, Kaser S, Ritsch A, Laimer M, Engl J, Paulweber B, Patsch JR, Ebenbichler CF. 2006. Cholesteryl ester transfer protein in metabolic syndrome. Obesity, 14: 812-818.
Shehzad A, Lee Y. 2010. Curcumin: Multiple molecular targets mediate multiple pharmacological actions: A review. Drugs Fut, 35: 113.
Shin SK, Ha TY, McGregor RA, Choi MS. 2011. Long‐term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. MolNutr Food Res, 55:1829- 1840.
Tavil Y, Sen N, Yazıc HU, Hızal F, Abacı A, Cengel A. 2007. Cengel, Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res, 120: 245-250.
Upadhyay S, Dixit M. 2015. Role of polyphenols and other phytochemicals on molecular signaling. Oxid Med Cell Longev, 2015.